Prof. Dr. med. Claudia Dorothea Baldus
Facts
Phone:
+49-431-500-22501
E-Mail:
claudia.baldus@uksh.de
Website:
Affiliations:
Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address:
Arnold-Heller-Str. 3, Bldg L
Curriculum vitae
Education/Training
Since 10/2018 | Director of Medicine, Hematology and Oncology, Christian-Albrechts-University Kiel, Medical Center Schleswig-Holstein, Campus Kiel, Germany |
2009-2018 | Senior Attending Physician, Dept. of Hematology and Oncology, Charité, Berlin |
99-01,03-09 | Resident, Charité, University Medicine Berlin, Germany |
2000 | Dr. med. (Thesis in medicine) |
1992-1999 | Medical School, Universities of Homburg and Berlin, Germany |
Research Experience/Academic Appointments
2020 | Vice Dean of the medical Faculty of the CAU, Christian-Albrechts-University, Kiel |
2020 | Director of the University Cancer Center Schleswig-Holstein (UCCSH) |
2018 | Full Professor of Medicine, Hematology and Oncology, Christian-Albrechts-University, Kiel |
2011-2016 | Professor (W3) of Hematology, Mildred-Scheel Stiftungsprofessur, Charité Berlin |
2005-2011 | Max-Eder-Nachwuchsgruppenförderung, CBF Charité Berlin |
2001-2003 | Post-doctoral fellow, Human Cancer Genetics Program, OSU, Columbus, USA (Mildred-Scheel Stipendiat) |
Important Scientific Prizes/Functions
2017-2019 | Speaker Joint Research Project – DKTK Joint Funding project |
2015-2019 | Speaker Joint Research Project – German Cancer Aid, Translational Oncology |
Since 2011 | Head of the trial research committee (GMALL Study Group) |
Project-related publications
P2, P1, P3, INF
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
P1, P3, P4, INF
Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications
P1, P3, P4, INF, Z
The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age
P1, P3, P4, Z, INF
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
P1, P3, P4, INF, Z
UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
P1, P3, P4, INF, Z
IGH Rearrangement Evolution in Adult KMT2Arearranged B-cell Precursor ALL: Implications for Cell-of-origin and MRD Monitoring
P1, P4, P6
In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets
P1, P3, P4, Z